These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3325010)

  • 61. [Type LADA diabetes--interrogation points].
    Otto-Buczkowska E
    Przegl Lek; 2013; 70(1):25-7. PubMed ID: 23789301
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Insulin dependence: problems with the classification of 100 consecutive patients.
    Wilson RM; Van der Minne P; Deverill I; Heller SR; Gelsthrope K; Reeves WG; Tattersall RB
    Diabet Med; 1985 May; 2(3):167-72. PubMed ID: 2952412
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Cytoplasmic islet cell antibodies and GAD antibodies in diagnosis of diabetes].
    Bieg S; Seissler J; Scherbaum WA
    Med Klin (Munich); 1995 Oct; 90(10):594-8. PubMed ID: 7500923
    [No Abstract]   [Full Text] [Related]  

  • 64. Importance of persistent cellular and humoral immune changes before diabetes develops: prospective study of identical twins.
    Tun RY; Peakman M; Alviggi L; Hussain MJ; Lo SS; Shattock M; Pyke DA; Bottazzo GF; Vergani D; Leslie RD
    BMJ; 1994 Apr; 308(6936):1063-8. PubMed ID: 8173426
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults.
    Vauhkonen I; Niskanen L; Knip M; Ilonen J; Vanninen E; Kainulainen S; Uusitupa M; Laakso M
    Diabetologia; 2000 Jan; 43(1):69-78. PubMed ID: 10663218
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Enhanced percentage of CD5+ B lymphocytes in newly diagnosed IDDM patients.
    Nicoletti F; Meroni PL; Barcellini W; Steinsväg PO; Di Mauro M; Lunetta M; Pagano M; Consoli U; Zanussi C
    Immunol Lett; 1990 Jan; 23(3):211-5. PubMed ID: 1689697
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.
    Sabbah E; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2455-9. PubMed ID: 8675560
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Diabetes mellitus in the elderly: a study on its clinical presentation, C-peptide reserve, and immunogenetic markers of insulin dependence].
    Seclén Santisteban S; Alvarez Huamán RI; Chantres Antoranz MT; Serrano Ríos M
    Rev Clin Esp; 1993 Mar; 192(4):162-8. PubMed ID: 8480059
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Life table analysis of the risk of type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. An 8-year prospective study.
    Deschamps I; Boitard C; Hors J; Busson M; Marcelli-Barge A; Mogenet A; Robert JJ
    Diabetologia; 1992 Oct; 35(10):951-7. PubMed ID: 1451952
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Correlation of islet cell antibodies and HLA-DR phenotypes with diabetes mellitus in adults.
    Gleichmann H; Zörcher B; Greulich B; Gries FA; Henrichs HR; Betrams J; Kolb H
    Diabetologia; 1984 Jul; 27 Suppl():90-2. PubMed ID: 6383926
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Islet-cell antibodies are seldom transient.
    Riley W; Maclaren N
    Lancet; 1984 Jun; 1(8390):1351-2. PubMed ID: 6145045
    [No Abstract]   [Full Text] [Related]  

  • 72. Analysis of children with type 1 diabetes in Korea: high prevalence of specific anti-islet autoantibodies, immunogenetic similarities to Western populations with "unique" haplotypes, and lack of discrimination by aspartic acid at position 57 of DQB.
    Yu J; Shin CH; Yang SW; Park MH; Eisenbarth GS
    Clin Immunol; 2004 Dec; 113(3):318-25. PubMed ID: 15507397
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals.
    Thivolet CH; Tappaz M; Durand A; Petersen J; Stefanutti A; Chatelain P; Vialettes B; Scherbaum W; Orgiazzi J
    Diabetologia; 1992 Jun; 35(6):570-6. PubMed ID: 1612231
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cytotoxic islet cell autoantibodies in newly diagnosed insulin-dependent diabetes mellitus: lack of correlation to age, residual beta cell function, HLA antigens and Coxsackie B virus antibodies.
    Hehmke B; Michaelis D; Hildmann W; Richter KV; Kohnert KD
    Diabetes Res; 1987 Feb; 4(2):73-7. PubMed ID: 3034475
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas.
    Pujol-Borrell R; Todd I; Doshi M; Gray D; Feldmann M; Bottazzo GF
    Clin Exp Immunol; 1986 Jul; 65(1):128-39. PubMed ID: 3098471
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Diabetes in chronic alcoholic pancreatitis. Role of residual beta cell function and insulin resistance.
    Cavallini G; Vaona B; Bovo P; Cigolini M; Rigo L; Rossi F; Tasini E; Brunori MP; Di Francesco V; Frulloni L
    Dig Dis Sci; 1993 Mar; 38(3):497-501. PubMed ID: 8444082
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [LADA--latent autoimmune diabetes in adults].
    Szelachowska M
    Endokrynol Pol; 2007; 58(3):246-51. PubMed ID: 17940991
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes.
    Endo T; Takizawa S; Tanaka S; Takahashi M; Fujii H; Kamisawa T; Kobayashi T
    Diabetes; 2009 Mar; 58(3):732-7. PubMed ID: 19001184
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Transient chylomicronemia preceding the onset of insulin-dependent diabetes in a young girl with no humoral markers of islet autoimmunity.
    Barbagallo CM; Averna MR; Citarrella R; Rizzo M; Amato M; Noto D; Pugliese A; Cefalù AB; Galluzzo A; Giordano C
    Eur J Endocrinol; 2004 Jun; 150(6):831-6. PubMed ID: 15191354
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunoprotection in spontaneous remission of type 1 diabetes: long-term follow-up results.
    Yilmaz MT; Devrim AS; Biyal F; Satman I; Arioğlu E; Dinççag N; Karsidağ K; Ozden I; Gürel N; Sipahioğlu F
    Diabetes Res Clin Pract; 1993 Feb; 19(2):151-62. PubMed ID: 8472630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.